stockrowResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Shares outstanding
ResMed Inc.'s shares outstanding at the end of fiscal 2026 was $146.1M, unchanged from fiscal 2025. At the end of the quarter to 30 September 2026 it was $143.4M. Over the past ten years it has ranged from $141.7M (fiscal 2016) to $147.6M (fiscal 2024); the current reading is higher than 58% of that period. ResMed Inc. ranks 14th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $146.1M | (0.87%) |
| FY2025 | $147.3M | (0.14%) |
| FY2024 | $147.6M | 0.06% |
| FY2023 | $147.5M | 0.28% |
| FY2022 | $147.0M | 0.40% |
| FY2021 | $146.5M | 0.55% |
| FY2020 | $145.7M | 0.81% |
| FY2019 | $144.5M | 0.35% |
| FY2018 | $144.0M | 1.08% |
| FY2017 | $142.5M | 0.55% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $143.4M | (1.81%) |
| Jun 2026 | $146.1M | 0.23% |
| Mar 2026 | $145.7M | (0.44%) |
| Dec 2025 | $146.4M | (0.36%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $1.3B |
| BAX Baxter International Inc. compare | $520.0M |
| ALC Alcon compare | $488.7M |
| BDX Becton, Dickinson and Company compare | $275.2M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $170.8M |
| RMD ResMed Inc. | $143.4M |
| ALGN Align Technology, Inc. compare | $71.0M |
| WST West Pharmaceutical Services, Inc. compare | $70.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement